Policy
PBM Investigation: How Pharmacy Benefit Managers Block Patient Access
BIO’s investigation into PBM practices reveals systemic barriers between patients and life-saving medications.
Read moreBiotechnology Innovation Organization
BIO is the world’s largest biotechnology trade association — advocating for members across health, agriculture, and the bioeconomy so science can reach the people who need it most.
Latest from the News Hub
Policy
SBIR Reauthorization: What It Means for Early-Stage Biotech
Events
BIO Investment & Growth Summit Recap: M&A Momentum Continues
Advocacy
BIO on the American Road: Stories from the Heartland
Policy
BIO’s investigation into PBM practices reveals systemic barriers between patients and life-saving medications.
Read moreNational Security
A new BIO report outlines how biotech underpins America’s defense, supply chain resilience, and global competitiveness.
Read moreIRA & Drug Pricing
Vital Transformation research commissioned by BIO quantifies the innovation toll of Medicare drug price negotiation.
Read moreFighting for patients’ access to life-saving therapies and a sustainable innovation ecosystem.
Advancing crop science and food security through biotechnology innovation.
Building a sustainable bioeconomy through biofuels, bio-based products, and green chemistry.
Protecting IP, capital formation, and R&D incentives that power the next breakthrough.
BIO’s preclinical safety committee providing guidance and best practices for members navigating drug development safety.
A co-production with BBC StoryWorks — video stories exploring how biotechnology shapes every aspect of life.
A curated library of tools, guides, and pathways for founders and emerging biotech companies navigating early growth.
On-demand and live educational sessions covering policy, science, and industry trends for members and the broader community.
An interactive map showing biotech’s economic contribution across all 50 states — jobs, investments, and patient reach.
Vital Transformation’s analysis of how IRA drug price controls threaten R&D pipelines and patient access to future medicines.
From the flagship BIO International Convention to intimate advocacy sessions, BIO events connect innovators, investors, and policymakers.
April 2026
BIO Investment & Growth (BIG) Summit
May 2026
BIO Patient Advocacy Coffee Chat
June 2026
BIO International Convention
The world’s leading one-on-one partnering system — connecting biotech companies, investors, and deal-makers at BIO events and beyond.
Connect on BIO Partnering BIO International Convention siteBIO members enjoy exclusive advocacy access, industry events, cost-saving programs, and a global network of innovators shaping the bioeconomy.
“BIO gives us a voice we couldn’t have on our own — opening doors in Washington that move the needle for our patients.”
Nkarta, Inc.
“The BIO Business Solutions program alone saves us more than our annual dues. And the advocacy is priceless.”
Virent Energy Systems
“As a founding member, BIO has been central to how we engage policymakers and the public on science that matters.”
Johnson & Johnson
“BIO’s committees connect us to the right experts and help us stay ahead of regulatory changes in our sector.”
LanzaTech
Full access to advocacy, events, cost-savings programs, and committees for established companies.
Purpose-built tiers for startups and early-stage companies — reduced dues, Early-Stage Hub access.
Universities and research institutions driving fundamental science behind tomorrow’s breakthroughs.
State biotech associations amplifying local ecosystems through BIO’s national reach and resources.
How biotech underpins America’s defense, supply chain, and global standing — and why we must protect it.
An investigation into pharmacy benefit managers and their outsized role in blocking patient access to medicines.
A patient family’s journey through rare disease, and the biotech innovation that changed everything.
A co-production with BBC StoryWorks. Explore how biotechnology shapes every corner of our world — from agriculture to medicine to energy.
Watch the seriesAccess the Early-Stage Resources Hub, reduced dues tiers, and a network of mentors and investors.
Learn moreAccess BIO’s policy research, position papers, comment letters, and advocacy resources on all key issues.
Explore policyAttend BIG Summit, use BIO Partnering™, and connect with dealmakers across the global biotech ecosystem.
View eventsAccess press releases, media kits, the I am BIO Podcast, and BIO’s storytelling resources.
Visit News HubBIO represents more than 1,200 biotech companies, academic institutions, state biotech centers, and related organizations across the U.S. and in 30+ countries. Our members are developing breakthrough products and technologies across healthcare, agriculture, and environmental applications.
Personalized medicine, rare disease, and novel therapies saving lives.
Feeding the world and protecting ecosystems through crop science.
Biofuels, bio-based products, and the renewable economy of tomorrow.